Trademark: 97767763
Word
TREAT-NMD
Status Date
Thursday, May 2, 2024
Filing Date
Wednesday, January 25, 2023
Published for Opposition
Tuesday, June 4, 2024
41 Medical education services, namely, training in the field of medical disorders and treatments; medical training and teaching; publishing of electronic and book medical publications; training in the field of medical disorders and their treatment; education services relating to pharmacology, namely, training in the field of pharmacology; organisation of conferences, educational exhibitions, competitions, and conducting seminars all in the field of medical training; arranging seminars in the field of medical training; information, advisory and consultancy services relating to the aforementioned services.
36 Financing and charitable funding services; providing monetary grants to charities; providing fundraising activities to support medical research; information, advisory and consultancy services relating to the aforementioned services
35 Business networking; business networking services; career networking services; online business networking services; market research in the fields of medicine, pharmaceuticals, and related scientific research; market campaigns in the fields of medicine, pharmaceuticals, and related scientific research; market canvassing in the fields of medicine, pharmaceuticals, and related scientific research; compilation of statistical data for scientific and pharmaceutical research for business and commercial purposes; advertising services to promote public awareness of medical conditions; advertising services to promote public awareness of medical issues; information, advisory and consultancy services relating to the aforementioned services
42 Research and development services in the fields of medicine, pharmaceuticals, and related scientific research; medical research services; consultancy relating to pharmaceutical research and development; medical and pharmacological research services; providing scientific information in the field of medical disorders and their treatment; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services relating to the aforementioned services
Jan 28, 2023
New Application Entered
Feb 14, 2023
New Application Office Supplied Data Entered
Aug 22, 2023
Teas Voluntary Amendment Received
Aug 22, 2023
Teas Amendment Entered Before Attorney Assigned
Oct 24, 2023
Assigned To Examiner
Oct 24, 2023
Non-Final Action Written
Oct 24, 2023
Non-Final Action E-Mailed
Oct 24, 2023
Notification Of Non-Final Action E-Mailed
Nov 10, 2023
Teas Response To Office Action Received
Apr 2, 2024
Assigned To Lie
Apr 3, 2024
Correspondence Received In Law Office
Apr 3, 2024
Teas/Email Correspondence Entered
Apr 3, 2024
Approved For Pub - Principal Register
Apr 16, 2024
Withdrawn From Pub - Og Review Query
Apr 23, 2024
Previous Allowance Count Withdrawn
Apr 29, 2024
Non-Final Action Written
Apr 29, 2024
Non-Final Action E-Mailed
Apr 29, 2024
Notification Of Non-Final Action E-Mailed
May 1, 2024
Examiners Amendment -Written
May 1, 2024
Examiners Amendment E-Mailed
May 1, 2024
Notification Of Examiners Amendment E-Mailed
May 1, 2024
Examiner's Amendment Entered
May 1, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24
